Pralsetinib-13C3-15N2

SZ目录编号:	SZ-P164D01
CAS 号	NA
分子式	C2413C3H32FN715N2O2
分子量	538.6
投资状态	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: (1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-(methyl-13C)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl-2,5-13C2-1,3-15N2)cyclohexane-1-carboxamide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: O=C([C@]1(CC[C@H]([13C]2=[15N]C([13C]([H])([H])[H])=[13CH]C(NC3=NNC(C)=C3)=[15N]2)CC1)OC)N[C@H](C4=CN=C(N5N=CC(F)=C5)C=C4)C

Pralsetinib-13C3-15N2 is chemically (1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-(methyl-13C)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl-2,5-13C2-1,3-15N2)cyclohexane-1-carboxamide. Pralsetinib-13C3-15N2 is supplied with detailed characterization data compliant with regulatory guideline. Pralsetinib-13C3-15N2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pralsetinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Pralsetinib-13C3-15N2

Contacts

Our Locations